
Celadon
CEL.LCeladon Pharmaceuticals Plc Price (CEL.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
61,893,906
(8.0266)%Revenue and Profitability
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenue | 0 | 0 | 2,000 | 24,000 | 75,000 |
Net Income | -151,697 | -1,398,945 | -4,783,000 | -17,411,000 | -7,140,000 |
FCF USD | 1,981 | -785,817 | -3,690,000 | -8,186,000 | -6,313,000 |
OCF USD | 1,981 | -77,574 | -3,148,000 | -6,100,000 | -5,972,000 |
Financial Health - DEBT
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
YTPD | 0.00 | -2.75 | -0.94 | -0.26 | -0.65 |
D/E | -22.34 | 29.52 | 1.81 | 0.60 | 1.49 |
CA/CL | 0.04 | 0.88 | 37.35 | 5.29 | 2.62 |
TA/TL | 0.96 | 1.03 | 33.50 | 2.13 | 1.53 |
Total Debt | 2,535,395 | 2,923,817 | 11,582,000 | 4,632,000 | 4,717,000 |
Management Performance
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ROIC | -1.35% | -31.47% | -14.60% | -42.67% | -68.65% |
ROE | 133.69% | -1,412.59% | -74.61% | -226.85% | -226.09% |
ROA | 0.00% | -27.52% | -72.38% | -131.39% | -77.43% |
NM % | - | - | -239,150.00% | -72,545.83% | -9,520.00% |
FCF / R% | 0.00% | 0.00% | -184,500.00% | -34,108.33% | -8,417.33% |
FCF / NI% | -1.31% | 74.15% | 77.15% | 47.02% | 88.42% |
Operating Margin (OM) | - | - | -543.10 | -950.29 | -409.75 |
Per Share
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EPS | -0.03 | -0.23 | -0.64 | -0.30 | -0.12 |
SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
OCPS | 0.00 | -0.01 | -0.42 | -0.11 | -0.10 |
FCPS | 0.00 | -0.13 | -0.49 | -0.14 | -0.10 |
BVPS | -0.02 | 0.02 | 0.85 | 0.12 | 0.05 |
Per Share - CAGR
Year | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAGR-EPS | -0.03 | -0.23 | -0.64 | -0.30 | -0.12 |
CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CAGR-OCPS | 0.00 | -0.01 | -0.42 | -0.11 | -0.10 |
CAGR-FCPS | 0.00 | -0.13 | -0.49 | -0.14 | -0.10 |
CAGR-BVPS | -0.02 | 0.02 | 0.85 | 0.12 | 0.05 |